合作与发展:系统性硬化症的未来——第一届国际系统性硬化症会议纪要
被引量：2
摘要
系统性硬化症（systemic sclerosis,SSc）作为欧洲抗风湿病联盟（European League Against Rheumatism,EULAR）近年来重点关注的“孤儿病”，逐渐得到了全球风湿病学者的高度重视。在此背景下，第一届国际系统性硬化症会议（1st SSWC）于2010年2月11日至13日在意大利文化之都佛罗伦萨市举行，来自64个国家的1215位代表（包括77位SSc患者）参加了此次盛会。
出处
《中华临床免疫和变态反应杂志》
2010年第2期151-154,共4页
Chinese Journal of Allergy & Clinical Immunology
同被引文献99
-
1Jelaska A, Arakawa M, Broketa G, et al. Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts Increased proportion of high collagen-producing cells in systemic sclerosis fibro- blasts [ J ]. Arthritis Rheum, 1996,39 : 1338-1346.
-
2Asano Y, Ihn H, Yamane K, et al. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts [ J ]. J Clin Invest ,2004,113:253-264.
-
3Ihn H,Yamane K, Kubo M, et al. Blockade of endogenous transfor- ming growth factor beta signaling prevents up-regulated collagen syn- thesis in scleroderma fibroblasts:association with increased expression of transforming growth factor beta receptors [J]. Arthritis Rheum, 2001,44:474-480.
-
4Yamane K,Ihn H,Kubo M,et al. Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts [ J ]. Arthritis Rheum ,2002,46:2421-2428.
-
5Asano Y,Ihn H,Jinnin M,et al. Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibro- blasts derived from localized scleroderma [J]. J Invest Dermatol, 2006,126 : 1761-1769.
-
6Asano Y,Ihn H, Yamane K, et al. Involvement of alphavbeta5 inte- grin-mediated activation of latent transforming growth factor betal in autocrine transforming growth factor beta signaling in systemic sclero- sis fibroblasts [ J]. Arthritis Rheum,2005,52:2897-2905.
-
7Asano Y, Ihn H, Yamane K, et al. Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fi- broblasts [ J ]. Am J Pathol,2006,168:499-510.
-
8Asano Y,Ihn H,Yamane K,et al. Increased expression levels of in- tegrin alphavbeta5 on scleroderma fibroblasts [J]. Am J Pathol, 2004,164 : 1275-1292.
-
9Mimura Y, Ihn H, Jinnin M, et al. Constitutive thrombospondin-l overexpression contributes to autocrine transforming growth factor-be- ta signaling in cultured scleroderma fibroblasts [ J]. Am J Pathol, 2005,166 : 1451-1463.
-
10Wipff PJ, Rifkin DB, Meister JJ, et al. Myofibroblast contraction acti- vates latent TGF-betal from the extracellular matrix [ J]. J Cell Biol, 2007,179 : 1311-1323.
-
1徐东,李梦涛,曾小峰.揭开系统性硬化症的神秘面纱[J].中华临床免疫和变态反应杂志,2009,3(3):237-240.
-
2曾红兵,孙世澜.欧洲狼疮性肾炎管理指南解读[J].内科急危重症杂志,2015,21(4):241-244. 被引量：5
-
3王昱,张卓莉.2016年欧洲抗风湿病联盟关于痛风治疗的建议:基于循证医学的证据[J].中华临床免疫和变态反应杂志,2017,11(1):95-98. 被引量：12
-
4徐金富,林洁璐,瞿介明.中国支气管扩张症诊治现状及面临的挑战[J].中华结核和呼吸杂志,2017,40(1):8-10. 被引量：54
-
5刘洪江,朱华群,贾园.2015年欧洲抗风湿病联盟/美国风湿病学会关于风湿性多肌痛管理建议[J].中华风湿病学杂志,2015,19(11):790-791. 被引量：5
-
6复发性成人类风湿关节炎患者生物治疗的预后研究[J].中华医学信息导报,2009,24(11):10-10.
-
7原源,宋丽清,关望,田巍.晚发型系统性硬化症合并消化道出血1例及文献回顾[J].临床荟萃,2015,30(2):225-227. 被引量：1
-
8刘萍,程莉,刘会.系统性硬化病治疗进展[J].西南军医,2009,11(5):942-944.
-
9唐鸿鹄,刘毅.系统性硬化症的诊治进展[J].实用医院临床杂志,2015,12(5):38-42. 被引量：8
